Literature DB >> 17118805

Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.

Davide Genini1, Carlo V Catapano.   

Abstract

Peroxisome proliferator-activated receptor (PPAR) alpha, gamma, and delta belong to the nuclear hormone receptor superfamily of ligand-activated transcription factors. PPARs regulate metabolic, developmental, and differentiation pathways and play important roles in human diseases, such as diabetes, atherosclerosis, cancer, and chronic inflammation. PPARs are the targets of drugs of widespread clinical use and represent promising targets for discovery of new therapeutics. The interaction of PPARs with the ubiquitin-proteasome system (UPS) has been the subject of limited investigation. The UPS plays an important role in regulating the levels and modulating ligand-dependent and-independent activity of nuclear receptors. This review highlights the current knowledge regarding the interactions of the UPS with PPARs and focuses on the differential regulation of the level and activity of the PPAR isotypes by the UPS in response to selective ligands. Understanding the connections between the UPS and PPARs can provide insights in the actions of existing drugs and raise the possibilities for development of more effective PPAR-based therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118805     DOI: 10.1080/10799890600928202

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  10 in total

Review 1.  Alcohol-induced steatosis in liver cells.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways.

Authors:  Larry A Denner; Jennifer Rodriguez-Rivera; Sigmund J Haidacher; Jordan B Jahrling; J Russ Carmical; Caterina M Hernandez; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Thomas G Wood; Kelly T Dineley
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

3.  PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.

Authors:  Naoki Tanaka; Kyoji Moriya; Kendo Kiyosawa; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models.

Authors:  Asaf A Qureshi; Xiaoyu Tan; Julia C Reis; Mostafa Z Badr; Christopher J Papasian; David C Morrison; Nilofer Qureshi
Journal:  Lipids Health Dis       Date:  2011-10-12       Impact factor: 3.876

5.  Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.

Authors:  Angelo Cerbone; Cristina Toaldo; Rosalba Minelli; Eric Ciamporcero; Stefania Pizzimenti; Piergiorgio Pettazzoni; Guglielmo Roma; Mario Umberto Dianzani; Chiara Ullio; Carlo Ferretti; Chiara Dianzani; Giuseppina Barrera
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

6.  PPARgamma and MEK Interactions in Cancer.

Authors:  Elke Burgermeister; Rony Seger
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

7.  Relevance of proteolysis and proteasome activation in fatty liver graft preservation: An Institut Georges Lopez-1 vs University of Wisconsin appraisal.

Authors:  Mohamed Amine Zaouali; Arnau Panisello-Roselló; Alexandre Lopez; Carlos Castro Benítez; Emma Folch-Puy; Agustín García-Gil; Teresa Carbonell; René Adam; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

8.  PPARα-Mediated Positive-Feedback Loop Contributes to Cold Exposure Memory.

Authors:  Soaad Alfaqaan; Tomoki Yoshida; Hiromi Imamura; Chihiro Tsukano; Yoshiji Takemoto; Akira Kakizuka
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

9.  Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.

Authors:  Davide Genini; Giuseppina M Carbone; Carlo V Catapano
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways.

Authors:  Zhangjun Cheng; Lei Liu; Xue-Jun Zhang; Miao Lu; Yang Wang; Volker Assfalg; Melanie Laschinger; Guido von Figura; Yoshiaki Sunami; Christoph W Michalski; Jörg Kleeff; Helmut Friess; Daniel Hartmann; Norbert Hüser
Journal:  Sci Rep       Date:  2018-08-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.